Effect of Cough and Cold Medication Restriction and Label Changes on Pediatric Ingestions Reported to United States Poison Centers

      Objective

      To determine the impact of industry and Food and Drug Administration initiatives implemented to limit the use of over-the-counter (OTC) cough and cold medications in children younger than 6 years of age.

      Study design

      This is a retrospective database study of OTC cough and cold medication ingestions reported to US poison centers between 2000 and 2010. Data analyzed from the National Poison Data System included the month and year of ingestion, reason for ingestion, health care utilization, and medical outcome. Ingestion frequencies were stratified by age and reason. Data were divided into pre- and postintervention periods for comparative analysis.

      Results

      Unintentional ingestions of OTC cough and cold medications decreased 33.4% and therapeutic errors by 46.0%. Health care facility referral declined for unintentional ingestions (28.9% <2 years of age, 19.9% 2-5 years of age, P < .0001) and therapeutic errors in children younger than 2 years of age (59.2%, P < .0001). Moderate and severe adverse outcomes decreased for unintentional ingestions in children younger than 2 years of age by 32.4% and by 21.3% in 2- to 5-year olds, P < .0001.

      Conclusions

      The restriction of OTC cough and cold medications has led to a decline in unintentional ingestions, therapeutic errors, health care facility referral, and serious medical outcomes in children younger than 2 years of age. There has also been a decline in ingestions in 2- to 5-year-old children.
      CHPA ( Consumer Healthcare Products Association), FDA ( Food and Drug Administration), NPDS ( National Poison Data System), OTC ( Over-the-counter)
      To read this article in full you will need to make a payment

      References

        • Kelly L.
        Pediatric cough and cold preparations.
        Pediatr Rev. 2004; 25: 115-123
      1. U. S. Food and Drug Administration Briefing information. Joint meeting on the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee. October 18-19, 2007. Available at: http://www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4323b1-00-index.htm. Accessed March 24, 2012.

      2. Consumer Healthcare Products Association. Pediatric oral cough and cold medications. Available at: http://www.chpa-info.org/media/resources/r_4519.pdf#search=%22pediatric%22. Accessed March 15, 2012.

        • Leeder J.S.
        • Kearns G.L.
        • Spielberg S.P.
        • van den Anker J.
        Understanding the relative roles of pharmacogenetics and ontogeny in pediatric drug development and regulatory science.
        J Clin Pharmacol. 2010; 50: 1377-1387
        • Schroeder K.
        • Fahey T.
        Over-the-counter medications for acute cough in children and adults in ambulatory settings.
        Cochrane Database Syst Rev. 2004; 4: CD001831
        • Smith M.B.
        • Feldman W.
        Over-the-counter cold medications. A critical review of clinical trials between 1950 and 1991.
        JAMA. 1993; 269: 2258-2263
        • CDC
        Infant deaths associated with cough and cold medications-two states, 2005.
        MMWR Morbid Mortal Wkly Rep. 2007; 56: 1-4
        • Schaefer M.K.
        • Shehab N.
        • Cohen A.L.
        • Budnitz D.S.
        Adverse events from cough and cold medications in children.
        Pediatrics. 2008; 121: 783-787
        • U. S. Food and Drug Administration
        Over the counter cough and cold medications for pediatric use; notice of public hearing.
        Fed Regist. 2008; 73: 50033-50036
        • U. S. Food and Drug Administration
        Public Health Advisory: nonprescription cough and cold medicine use in children.
        FDACDER, Rockville2008 (Available at:) (Accessed March 24, 2012)
        • Connonlly C.
        Drug makers issue warning.
        Washington Post. 2008; : A02
      3. Consumer Healthcare Products Association 2012. Children's OTC cough and cold medicines. Available at: http://www.chpa-info.org/issues/Childrens_CC_Overview.aspx. Accessed December 12, 2012.

      4. U.S. Food and Drug Administration 2012. Using over-the-counter cough and cold products in children. Available at: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm048515.htm. Accessed December 12, 2012.

        • Klein-Schwartz W.
        • Sorkin J.D.
        • Doyon S.
        Impact of the voluntary withdrawal of over-the-counter cough and cold medications on pediatric ingestions reported to poison centers.
        Pharmacoepidemiol Drug Safety. 2010; 19: 819-824
        • Forrester M.B.
        Effect of cough and cold medication withdrawal and warning on ingestions by young children reported to Texas poison centers.
        Pediatr Emerg Care. 2012; 28: 510-513
        • Shehab N.
        • Schaefer M.K.
        • Kegler S.R.
        • Budnitz D.S.
        Adverse events from cough and cold medications after a market withdrawal of products labeled for infants.
        Pediatrics. 2010; 126: 1100-1107
        • Bronstein A.C.
        • Spyker D.A.
        • Cantilena L.R.
        • Green J.L.
        • Rumack B.H.
        • Dart R.C.
        2010 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report.
        Clin Toxicol. 2011; 49: 910-941
      5. U.S. Census Bureau (2000). Census 2000 Summary File 1. Available at http://factfinder2. Census.gov. Accessed May, 10, 2012.

      6. U.S. Census Bureau, Population Division. Annual Estimates of Resident Population by Sex and Age for the United States: April 1, 2000 to July 1, 2009. Available at: http://factfinder2.census.gov. Accessed May 15, 2012.

      7. U.S. Census (2010). Resident Population of the 50 States, District of Columbia, and Puerto Rico: 2010 Census. Available at: http://2010.census.gov/news/press-kits/apportionment/apport.html. Accessed May 20, 2012.

        • Garbitt J.M.
        • Sterkel R.
        • Banister C.
        • Walber C.
        • Strunk R.C.
        Physician and parent response to the FDA advisory about the use of over-the-counter cough and cold medications.
        Acad Pediatr. 2010; 10: 64-69
        • Hanoch Y.
        • Gummerum M.
        • Miron-Shatz T.
        • Himmelstein M.
        Parent's decision following the Food and Drug Administration recommendation: the case of over-the-counter cough and cold medication.
        Child Care Health Dev. 2010; 36: 795-804
        • Yaghmai B.F.
        • Cordts C.
        • Ahler-Schmidt C.R.
        • Issa B.A.
        • Warren R.C.
        One community's perspective on the withdrawal of cough and cold medications for infants and young children.
        Clin Pediatr. 2010; 49: 310-315
      8. American Academy of Pediatrics 2012. Withdrawal of cold medicines: addressing parent concerns. Available at: http://www.aap.org/en-us/professional-resources/practice-support/Pages/Withdrawal-of-Cold-Medicines-Addressing-Parent-Concerns.aspx. Accessed December 13, 2012.

        • Doyon S.
        • Tra Y.
        • Klein-Schwartz W.
        Decrease in therapeutic errors involving prescription cough and cold medications in young children.
        J Pediatr Pharmacol Ther. 2012; 17: 84-87